Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad
- 1 March 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 29 (3), 397-403
- https://doi.org/10.1002/stem.596
Abstract
Sarcomas are nonepithelial, nonhematopoietic malignant tumors that arise from the embryonic mesoderm. Despite their rarity, less than 10% of all cancers, sarcomas are accountable for relatively high morbidity and mortality especially in children and adolescents. Although there are some hereditary conditions predisposing sarcoma, such as the Li-Fraumeni and Retinoblastoma syndrome, the vast majority of these tumors are sporadic. Based on their histological morphology, sarcomas have been divided into a broad spectrum of subtypes recognized in the 2002 WHO classification of tumors. This wide lineage range suggests that sarcomas originate from either many committed different cell types or from a multipotent cell, subsequently driven into a certain lineage. Mesenchymal stem cells (MSCs) are able to differentiate into many cell types needed to create mature structures like vessels, muscle, and bone. These multipotent cells can be isolated from several adult human tissues and massively expanded in culture, making them both of use for research as well as potential beneficial therapeutical agents. For this reason MSCs are being extensively studied, however, concerns have raised about whether they are the putative originating cells of sarcoma and their questionable role in cancer progression. Recent accomplishments in the field have broadened our knowledge of MSCs in relation to sarcoma origin, sarcoma treatment and the safety of MSCs usage in therapeutic settings.Keywords
This publication has 54 references indexed in Scilit:
- Variations in stromal signatures in breast and colorectal cancer metastasesThe Journal of Pathology, 2010
- Rb regulates fate choice and lineage commitment in vivoNature, 2010
- Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?Neuropharmacology, 2010
- Therapeutic potential of adult bone marrow‐derived mesenchymal stem cells in diseases of the skeletonJournal of Cellular Biochemistry, 2010
- Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathwaysBritish Journal of Cancer, 2009
- Genetically transforming human mesenchymal stem cells to sarcomasCancer, 2009
- Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumorsCancer, 2008
- Osteosarcoma Development and Stem Cell DifferentiationClinical Orthopaedics and Related Research, 2008
- Mesenchymal Stem Cell Features of Ewing TumorsCancer Cell, 2007
- Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaThe Journal of Experimental Medicine, 2006